Managing treatment fatigue in patients with multiple sclerosis on long-term therapy: the role of multiple sclerosis nurses

References

• CompstonAColesAMultiple sclerosisLancet200837296481502151718970977
   PubMed Web of Science ®Google Scholar
• PyatakEAFlorindezDWeigensbergMJAdherence decision making in the everyday lives of emerging adults with type 1 diabetesPatient Prefer Adherence2013770971823935361
   PubMed Web of Science ®Google Scholar
• BrownMTBussellJKMedication adherence: WHO cares?Mayo Clin Proc201186430431421389250
   PubMed Web of Science ®Google Scholar
• MenzinJCaonCNicholsCWhiteLAFriedmanMPillMWNarrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosisJ Manag Care Pharm2013191 Suppl AS24S4023383731
   PubMed Web of Science ®Google Scholar
• SteinbergSCFarisRJChangCFChanATankersleyMAImpact of adherence to interferons in the treatment of multiple sclerosis: a non-experimental, retrospective, cohort studyClin Drug Investig201030289100
   PubMed Web of Science ®Google Scholar
• HalperJThe evolving role of the nurse in the treatment of multiple sclerosisJ Neurosci Nursing2009414E1E13
   Google Scholar
• KoudriavtsevaTOnestiEPestalozzaIFSperdutiIJandoloBThe importance of physician-patient relationship for improvement of adherence to long-term therapy: data of survey in a cohort of multiple sclerosis patients with mild and moderate disabilityNeurol Sci201233357558421927880
   PubMed Web of Science ®Google Scholar
• DevonshireVLapierreYMacdonellRGAP Study GroupThe Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosisEur J Neurol2011181697720561039
   PubMed Web of Science ®Google Scholar
• CostelloKKennedyPScanzilloJRecognizing nonadherence in patients with multiple sclerosis and maintaining treatment adherence in the long termMedscape J Med200810922519008986
   PubMedGoogle Scholar
• RioJPorcelJTéllezNFactors related with treatment adherence to interferon beta and glatiramer acetate therapy in multiple sclerosisMult Scler200511330630915957512
   PubMed Web of Science ®Google Scholar
• RuggieriRMSettipaniNVivianoLLong-term interferon-beta treatment for multiple sclerosisNeurol Sci200324536136414716534
   PubMed Web of Science ®Google Scholar
• O’RourkeKEHutchinsonMStopping beta-interferon therapy in multiple sclerosis: an analysis of stopping patternsMult Scler2005111465015732266
   PubMed Web of Science ®Google Scholar
• PattenSBAntidepressant treatment for major depression in multiple sclerosis: the evolving efficacy literatureInt J MS Care2009114174179
   Google Scholar
• DeleuDAlsharoqiIAl JumahMAWill new injection devices for interferon β-1a s.c. affect treatment adherence in patients with multiple sclerosis? An expert opinion in the Middle EastInt J Neurosci2011121417117521329472
   PubMed Web of Science ®Google Scholar
• MohrDCBoudewynACLikoskyWLevineEGoodkinDEInjectable medication for the treatment of multiple sclerosis: the influence of self-efficacy expectations and injection anxiety on adherence and ability to self-injectAnn Behav Med200123212513211394554
   PubMed Web of Science ®Google Scholar
• MoriskyDEAngAKrousel-WoodMWardHJPredictive validity of a medication adherence measure in an outpatient settingJ Clin Hypertens (Greenwich)200810534835418453793
   PubMed Web of Science ®Google Scholar
• MoriskyDEMalotteCKChoiPA patient education program to improve adherence rates with antituberculosis drug regimensHealth Educ Q19901732532672228629
   PubMedGoogle Scholar
• MoriskyDEGreenLWLevineDMConcurrent and predictive validity of a self-reported measure of medication adherenceMed Care198624167743945130
   PubMed Web of Science ®Google Scholar
• BrandesDWCallenderTLathiEO’LearySA review of disease-modifying therapies for MS: maximizing adherence and minimizing adverse eventsCurr Med Res Opin2009251779219210141
   PubMed Web of Science ®Google Scholar
• Dhib-JalbutSMarkowitzCPatelPBoatengFRamettaMSTART Study GroupThe combined effect of nursing support and adverse event mitigation on adherence to interferon beta-1b therapy in early multiple sclerosis: the START studyInt J MS Care201214419820824453752
   PubMedGoogle Scholar
• Langer-GouldAMosesHHMurrayTJStrategies for managing the side effects of treatments for multiple sclerosisNeurology200463 11 Suppl 5S35S4115596735
   PubMed Web of Science ®Google Scholar
• PhillipsJTFoxEGraingerWTuccilloDLiuSDeykinAAn open-label, multicenter study to evaluate the safe and effective use of the single-use autoinjector with an Avonex® prefilled syringe in multiple sclerosis subjectsBMC Neurol20111112621999176
   PubMed Web of Science ®Google Scholar
• BrochetBLemaireGBeddiafAl’Epicure study groupReduction of injection site reactions in multiple sclerosis (MS) patients newly started on interferon beta 1b therapy with two different devicesRev Neurol (Paris)20061626–7735740 French [with English abstract]16840982
   PubMed Web of Science ®Google Scholar
• PozzilliCSchweikertBEcariUOentrichWBuggeJPQuality of life and depression in multiple sclerosis patients: longitudinal results of the BetaPlus studyJ Neurol2012259112319232822527232
   PubMed Web of Science ®Google Scholar
• PozzilliCSchweikertBEcariUOentrichWBetaPlus Study GroupSupportive strategies to improve adherence to IFN β-1b in multiple sclerosis – results of the βPlus observational cohort studyJ Neurol Sci20113071–212012621636099
   PubMed Web of Science ®Google Scholar
• MooreLAKaufmanMDAlgozzineRIrishNMartinMPoseyCRAdherence to therapy: using an evidence-based protocolRehabil Nurs200732622723218065143
   PubMed Web of Science ®Google Scholar
• JollyHSimpsonKBishopBImpact of warm compresses on local injection-site reactions with self-administered glatiramer acetateJ Neurosci Nurs200840423223918727339
   PubMed Web of Science ®Google Scholar
• HammerWIGraston technique®: a contemporary instrument assisted mobilization method for the evaluation and treatment of soft tissue lesionsSchliepRFindleyTWChaitowLHuijingPFascia: the Tensional Network of the Human Body: the Science and Clinical Applications in Manual and Movement Therapy1st edPhiladelphia, PAElsevier Ltd2012391396
   Google Scholar
• MillerNHMotivational interviewing as a prelude to coaching in healthcare settingsJ Cardiovasc Nurs201025324725120386250
   PubMed Web of Science ®Google Scholar
• DuffAJLatchfordGJMotivational interviewing for adherence problems in cystic fibrosis; evaluation of training healthcare professionalsJ Clin Med Res20135647548024171060
   PubMedGoogle Scholar
• Moss-MorrisRDennisonLLandauSYardleyLSilberEChalderTA randomized controlled trial of cognitive behavioral therapy (CBT) for adjusting to multiple sclerosis (the saMS trial): does CBT work and for whom does it work?J Consult Clin Psychol201381225126222730954
   PubMed Web of Science ®Google Scholar
• FoxRJSalterARTyryTTreatment discontinuation and disease progression with injectable disease-modifying therapies: findings from the north american research committee on multiple sclerosis databaseInt J MS Care201315419420124453783
   PubMedGoogle Scholar